NWSA vs ZTS · rev $9.03B vs P/E 25, rev $2.47B
NWSA (NWSA) versus Zoetis Inc (ZTS) — a side-by-side from cached financials, not a winner call.
NWSA (NWSA) common stock.
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported NWSA revenue for 2026-06-30 was $9.03B. Net income was $573.0M. Revenue was up 328.1% from 2025-06-30 to 2026-06-30. NWSA currently screens at market cap $0.
Latest reported ZTS revenue for 2026-06-30 was $2.47B. Net income was $691.0M. Revenue was up 9.1% from 2026-03-31 to 2026-06-30. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
NWSA currently screens at market cap $0. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
Not investment advice. Open the NWSA and ZTS stock pages for the full models.
Not investment advice.